Crossmark

L-serine treatment in a patient with refractory epilepsy due to a GRIN2A missense mutation

Crossref DOI link: https://doi.org/10.1007/s13760-024-02616-8

Published Online: 2024-08-06

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Shin, Hui Jin https://orcid.org/0000-0002-1541-2564
Ko, Ara https://orcid.org/0000-0002-3008-8432
Kim, Se Hee https://orcid.org/0000-0001-7773-1942
Kang, Hoon-Chul https://orcid.org/0000-0002-3659-8847
Lee, Joon Soo https://orcid.org/0000-0001-9036-9343
License Information

Text and Data Mining valid from 2024-08-06

Version of Record valid from 2024-08-06
More Information

Article History

Received: 11 June 2024

Accepted: 20 July 2024

First Online: 6 August 2024

Declarations

:

: The authors declare that they have no conflict of interest.